Data / Drug companies / Emnar Pharma Private Limited
Emnar Pharma Private Limited: 24 products in the FDA NDC directory, labeler code 71901
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Emnar Pharma Private Limited (labeler code 71901) lists 24 products in the FDA National Drug Code Directory. By type: 24 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on August 24, 2025.
The request: Watch Emnar Pharma Private Limited (FDA labeler code 71901): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71901
- Products in commercial distribution
- 24
- Packages
- 24
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 1, Schedule V 1
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- January 1, 1987
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 24 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 24 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 22 | 91.7% |
| Injection | 1 | 4.2% |
| Tablet | 1 | 4.2% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Lamivudine | 71901-629 | Powder | Bulk ingredients | August 24, 2025 |
| Capecitabine | 71901-628 | Powder | Bulk ingredients | August 24, 2025 |
| Calcium carbonate | 71901-626 | Powder | Bulk ingredients | August 24, 2025 |
| Sodium valproate | 71901-625 | Powder | Bulk ingredients | August 24, 2025 |
| Sodium chloride | 71901-624 | Powder | Bulk ingredients | August 24, 2025 |
| Empagliflozin (efg) | 71901-623 | Powder | Bulk ingredients | August 24, 2025 |
| Potassium bicarbonate | 71901-622 | Powder | Bulk ingredients | August 24, 2025 |
| Potassium chloride | 71901-621 | Powder | Bulk ingredients | August 24, 2025 |
| Apixaban | 71901-620 | Powder | Bulk ingredients | August 23, 2025 |
| Lithium carbonate | 71901-619 | Powder | Bulk ingredients | August 23, 2025 |
| Tenofovir disoproxil fumarate | 71901-618 | Powder | Bulk ingredients | August 23, 2025 |
| Pridinol mesilate | 71901-617 | Powder | Bulk ingredients | August 23, 2025 |
| Bupropion hydrochloride | 71901-615 | Powder | Bulk ingredients | August 20, 2025 |
| Pitolisant hydrochloride | 71901-614 | Powder | Bulk ingredients | March 19, 2025 |
| Zonisamide | 71901-613 | Powder | Bulk ingredients | March 18, 2025 |
| Lacosamide | 71901-611 | Powder | Bulk ingredients | December 27, 2023 |
| Gabapentin | 71901-609 | Powder | Bulk ingredients | April 19, 2022 |
| Empagliflozin | 71901-608 | Powder | Bulk ingredients | February 17, 2022 |
| Dapagliflozin propanediol monohydrate | 71901-607 | Powder | Bulk ingredients | November 12, 2021 |
| Levetiracetam | 71901-605 | Powder | Bulk ingredients | December 7, 2020 |
| Acotiamide hydrochloride hydrate | 71901-603 | Tablet | Bulk ingredients | January 31, 2018 |
| Tramadol hydrochloride | 71901-601 | Powder | Bulk ingredients | January 31, 2018 |
| Sodium bicarbonate | 71901-604 | Injection | Bulk ingredients | December 1, 2017 |
| Ciprofloxacin hydrochloride | 71901-602 | Powder | Bulk ingredients | January 1, 1987 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.